Related Experiment Videos
TNM residual tumor classification revisited
Christian Wittekind1, Carolyn C Compton, Frederick L Greene
1Institute of Pathology, University Clinic of Leipzig, Leipzig, Germany. wittc@medizin.uni-leipzig.de
Cancer
|May 17, 2002
Summary
The residual tumor (R) classification is vital for cancer patient prognosis after treatment. Consistent application of the R classification is essential for accurate treatment outcome comparison and data standardization.
Area of Science:
- Oncology
- Surgical Pathology
- Cancer Research
Background:
- Completeness of tumor removal significantly impacts cancer patient prognosis.
- The residual tumor (R) classification, part of the TNM system, quantifies treatment success.
- Current R classification use suffers from misinterpretation and inconsistent application, limiting clinical utility.
Purpose of the Study:
- To analyze the literature on the R classification's use and prognostic significance.
- To discuss the prognostic importance of the R classification across various tumor types.
- To identify and address challenges in the application of the R classification.
Main Methods:
- Literature review of studies on the R classification.
- Analysis of the prognostic value of the R classification in cancer treatment.
- Examination of issues and special considerations in R classification use.
Main Results:
- The R classification demonstrates strong prognostic importance for diverse tumor types.
- Identified challenges and problems associated with the current application of the R classification.
- Addressed specific issues pertinent to the utilization of the R classification in clinical practice.
Conclusions:
- The R classification is a robust predictor of patient prognosis.
- Consistent application of the R classification aids in comparing treatment outcomes.
- Standardized use and interpretation are crucial for reliable post-treatment data collection.